Positron emission tomography imaging of adrenal masses:18F-fluorodeoxyglucose and the 11β-hydroxylase tracer11C-metomidate
✍ Scribed by Georg Zettinig; Markus Mitterhauser; Wolfgang Wadsak; Alexander Becherer; Christian Pirich; Heinrich Vierhapper; Bruno Niederle; Robert Dudczak; Kurt Kletter
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 295 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Positron emission tomography (PET) scans of primary brain tumors were performed in pediatric patients to examine whether metabolic characteristics could be used as an index of clinical aggressiveness. ## METHODS Twenty‐seven pediatric patients with untreated primary cen
## Background: Accurate preoperative staging is an important but difficult problem in determining therapy for patients with esophageal carcinoma. positron emission tomography (pet) is used with [methyl-(11)c]choline ((11)c-choline) and 2-[(18)f]fluoro-2-deoxy-d-glucose ((18)f-fdg) to detect a varie
Microvascular invasion is a poor prognostic indicator of the recurrence of hepatocellular carcinoma (HCC) after surgical treatment. Positron emission tomography (PET) with [ 18 F]fludeoxyglucose ([ 18 F]FDG) as a tracer has been employed to predict the prognosis before surgery for various kinds of t